myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course.

44 small cell lung cancer cell lines established from 227 patients were studied for myc family DNA amplification (c-myc, N-myc, and L-myc). Two of 19 lines (11%) established from untreated patients' tumors had DNA amplification (one N-myc and one L-myc), compared with 11 of 25 (5 c-myc, 3 N-myc, and 3 L-myc) cell lines (44%) established from relapsed patients' tumors (P = 0.04). The 19 patients who had tumor cell lines established before chemotherapy treatment survived a median of 14 wk compared with 48 wk for the 123 extensive stage patients who did not have cell lines established (P less than 0.001). Relapsed patients whose cell lines had c-myc DNA amplification survived a shorter period (median of 33 wk) than patients whose cell lines did not have c-myc amplification (median of 53 wk; P = 0.04). We conclude that myc family DNA amplification is more common in tumor cell lines established from treated than untreated patients' tumors, and c-myc amplification in treated patients' tumor cell lines is associated with shortened survival.

[1]  J. Battey,et al.  Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene. , 1986, The Journal of clinical investigation.

[2]  S. Baylin,et al.  Gene amplification of c-myc and N-myc in small cell carcinoma of the lung. , 1986, Science.

[3]  J. Battey,et al.  Human small-cell lung cancers show amplification and expression of the N-myc gene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Yokota,et al.  Alterations of myc, myb, and rasHa proto-oncogenes in cancers are frequent and show clinical correlation. , 1986, Science.

[5]  A. Feinberg,et al.  Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Battey,et al.  L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer , 1985, Nature.

[7]  H. Sather,et al.  Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. , 1985, The New England journal of medicine.

[8]  R. Makuch,et al.  Patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. Data on potential cures, chronic toxicities, and late relapses after a five- to eleven-year follow-up. , 1985, Annals of internal medicine.

[9]  J. Battey,et al.  The human vasopressin gene is linked to the oxytocin gene and is selectively expressed in a cultured lung cancer cell line. , 1985, The Journal of biological chemistry.

[10]  J. Minna,et al.  Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties. , 1985, Cancer research.

[11]  G. Bepler,et al.  Establishment and identification of small cell lung cancer cell lines having classic and variant features. , 1985, Cancer research.

[12]  J. Bergh,et al.  Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer. , 1985, Cancer research.

[13]  W. Benedict,et al.  Erratum: Expression and amplification of the N-myc gene in primary retinoblastoma , 1984, Nature.

[14]  Wen-Hwa Lee,et al.  Expression and amplification of the N-myc gene in primary retinoblastoma , 1984, Nature.

[15]  T. Sugimura,et al.  Amplification of the c-myc oncogene in human stomach cancers. , 1984, Gan.

[16]  H. Varmus,et al.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. , 1984, Science.

[17]  J. Minna,et al.  Small cell lung cancer 1973-1983: early progress and recent obstacles. , 1984, International journal of radiation oncology, biology, physics.

[18]  D. Kozbor,et al.  Amplification of the c-myc oncogene in one of five human breast carcinoma cell lines. , 1984, Cancer research.

[19]  F. Alt,et al.  Transposition and amplification of oncogene-related sequences in human neuroblastomas , 1983, Cell.

[20]  J. Trent,et al.  Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour , 1983, Nature.

[21]  J. Minna,et al.  Amplification and expression of the c-myc oncogene in human lung cancer cell lines , 1983, Nature.

[22]  P. Leder,et al.  The human c-myc oncogene: Structural consequences of translocation into the igh locus in Burkitt lymphoma , 1983, Cell.

[23]  H. Varmus,et al.  Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Groudine,et al.  Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line , 1982, Nature.

[25]  J. Minna,et al.  A nonrandom chromosomal abnormality, del 3p(14-23), in human small cell lung cancer (SCLC). , 1982, Cancer genetics and cytogenetics.

[26]  T. Waldmann,et al.  Clustered arrangement of immunoglobulin λ constant region genes in man , 1981, Nature.

[27]  R. Makuch,et al.  Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy. , 1981, The American review of respiratory disease.

[28]  T. Waldmann,et al.  Clustered arrangement of immunoglobulin lambda constant region genes in man. , 1981, Nature.

[29]  E. Frenkel,et al.  Growth characteristics of neuroblastoma in vitro correlate with patient survival. , 1980, Transactions of the Association of American Physicians.

[30]  R. Makuch,et al.  Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma. , 1979, Cancer treatment reports.

[31]  R. Livingston,et al.  Small-cell carcinoma of the lung: combined chemotherapy and radiation: a Southwest Oncology Group study. , 1978, Annals of internal medicine.

[32]  E. Southern.  Detection of specific sequences among DNA fragments separated by gel electrophoresis. , 1975, Journal of molecular biology.

[33]  E. Gehan.  A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. , 1965, Biometrika.

[34]  Emil Frei,et al.  Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide , 1960 .

[35]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .